Global efforts invested in the prevention and treatment of cancer need to be repositioned to
develop safe, effective, and economic anticancer therapeutics by adopting rational …

While majority of the current treatment approaches for cancer remain expensive and are
associated with several side effects, development of new treatment modalities takes a …

Cancer is one of the primary global causes of death, thus addressing cancer therapy
remains a significant challenge, especially in cases where cancers exhibit resistance to …

Repurposing is a drug development strategy that seeks new medical treatments using
existing licensed drugs rather than from new molecular entities. There has been increasing …

Human malignancies are one of the major health-related issues though out the world and
anticipated to rise in the future. The development of novel drugs/agents requires a huge …

Background: Research into repositioning known drugs to treat cancer other than the
originally intended disease continues to grow and develop, encouraged in part, by several …

Drug repurposing for cancer therapy is currently a hot topic of research. Theoretically, in
contrast to the known hurdles of developing new molecular entities, the approach of …

Cancer, a complex and multifactorial disease, presents a significant challenge to global
health. Despite significant advances in surgical, radiotherapeutic and immunological …

The repurposing of existing non-cancer drugs is a potential source of new treatment options
for cancer patients with high unmet medical needs. While scientific research is progressing …

Cancer poses a significant global health challenge, with predictions of increasing
prevalence in the coming years due to limited prevention, late diagnosis, and inadequate …